Telix Pharmaceuticals Limited
TLPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $5,211 | -$104,079 | -$80,510 |
| Dep. & Amort. | $0 | $6,924 | $5,379 | $5,174 |
| Deferred Tax | $0 | $0 | -$13,378 | -$14,199 |
| Stock-Based Comp. | $0 | $8,786 | $8,114 | $1,322 |
| Change in WC | -$64,271 | -$57,534 | -$1,007 | -$2,630 |
| Other Non-Cash | $107,300 | $60,497 | $41,001 | $31,515 |
| Operating Cash Flow | $43,029 | $23,884 | -$63,970 | -$59,328 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14,322 | -$9,679 | -$13,861 | -$1,339 |
| Net Acquisitions | -$34,694 | -$1,484 | -$973 | $0 |
| Inv. Purchases | -$51,988 | -$13,155 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$34,169 | -$1,171 | -$2,163 | -$1,387 |
| Investing Cash Flow | -$135,173 | -$25,489 | -$16,997 | -$2,726 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $652,808 | $5,756 | $3,001 | -$340 |
| Stock Issued | $999 | $6,652 | $123,161 | $3,782 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$14,884 | -$2,222 | -$1,264 | -$596 |
| Financing Cash Flow | $638,923 | $10,186 | $174,960 | $2,846 |
| Forex Effect | $40,330 | -$1,673 | $299 | $3,300 |
| Net Chg. in Cash | $587,109 | $6,908 | $94,292 | -$55,908 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $123,237 | $116,329 | $22,037 | $77,945 |
| End Cash | $710,346 | $123,237 | $116,329 | $22,037 |
| Free Cash Flow | $8,997 | $13,090 | -$77,831 | -$60,667 |